EMBO Molecular Medicine

Papers
(The H4-Index of EMBO Molecular Medicine is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer358
Whole‐brain microscopy reveals distinct temporal and spatial efficacy of anti‐Aβ therapies242
Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders152
Circulating proteomic panels for risk stratification of intracranial aneurysm and its rupture147
Depressive patient‐derived GABA interneurons reveal abnormal neural activity associated with HTR2C137
A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability124
When fat meets the gut—focus on intestinal lipid handling in metabolic health and disease82
Targeting conformational changes in C‐reactive protein to inhibit pro‐inflammatory actions70
Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis70
Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking69
HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy67
Flower lose, a cell fitness marker, predicts COVID‐19 prognosis65
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7 ‐deficient cells60
IQCN disruption causes fertilization failure and male infertility due to manchette assembly defect59
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis54
Elongator and the role of its subcomplexes in human diseases53
Glomerular endothelial cell senescence drives age‐related kidney disease through PAI‐153
Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain53
Identification of treatment‐induced vulnerabilities in pancreatic cancer patients using functional model systems51
Metformin rescues migratory deficits of cells derived from patients with periventricular heterotopia51
Eosinophil‐derived IL ‐4 is necessary to establish the inflammatory structure in innate inflammation50
Diagnostic biomarkers for active tuberculosis: progress and challenges50
ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo48
Systemic inflammation after stroke: implications for post‐stroke comorbidities48
Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy45
Nerve regeneration by interferon intervention in aging brain45
Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model45
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer44
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers44
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination44
Single‐cell profiling of muscle‐infiltrating T cells in idiopathic inflammatory myopathies43
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE‐PTP sequestration42
ALX1 ‐related frontonasal dysplasia results from defective neural crest cell development and migration40
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT39
Macrophage colony‐stimulating factor as a weapon against cytomegalovirus39
Looking at a baby's heart through the lens of the mother's blood39
Optimizing the Cas13 antiviral train: cargo and delivery38
Mining the bacterial genome to discover new antimicrobial molecules38
0.077894926071167